Literature DB >> 32037250

Is it too early to investigate survival outcomes of the new US heart allocation system?

William F Parker1, Matthew M Churpek2, Allen S Anderson3.   

Abstract

Entities:  

Year:  2020        PMID： 32037250      PMCID： PMC7565081          DOI： 10.1016/j.healun.2020.01.1343

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

Review 1.  Survival probabilities (the Kaplan-Meier method).

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1998-12-05

2.  Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.

Authors:  Federico Campigotto; Edie Weller
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

3.  An early investigation of outcomes with the new 2018 donor heart allocation system in the United States.

Authors:  Rebecca Cogswell; Ranjit John; Jerry D Estep; Sue Duval; Ryan J Tedford; Francis D Pagani; Cindy M Martin; Mandeep R Mehra
Journal:  J Heart Lung Transplant       Date:  2019-11-20       Impact factor: 10.247
  3 in total
  3 in total

1.  Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis.

Authors:  Oliver K Jawitz; Marat Fudim; Vignesh Raman; Benjamin S Bryner; Adam D DeVore; Robert J Mentz; Carmelo Milano; Chetan B Patel; Jacob N Schroder; Joseph G Rogers
Journal:  JACC Heart Fail       Date:  2020-05-14       Impact factor: 12.035

2.  Outcomes in the 2018 UNOS donor heart allocation system: A perspective on disparate analyses.

Authors:  Anubodh S Varshney; Sameer A Hirji; Michael M Givertz
Journal:  J Heart Lung Transplant       Date:  2020-08-26       Impact factor: 10.247

3.  An updated estimate of posttransplant survival after implementation of the new donor heart allocation policy.

Authors:  Kevin A Lazenby; Nikhil Narang; Kenley M Pelzer; Gege Ran; William F Parker
Journal:  Am J Transplant       Date:  2022-01-06       Impact factor: 9.369
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.